
KLOW is a four-component research blend combining GHK-Cu, BPC-157, TB-500 and KPV, studied across overlapping tissue-repair, matrix-remodelling and anti-inflammatory pathways. Supplied lyophilised for laboratory research use only.
KLOW is a high-content research blend that combines four of the most-studied repair and remodelling peptides in a single lyophilised vial: the copper tripeptide GHK-Cu, the pentadecapeptide BPC-157, the actin-regulating TB-500, and the α-MSH-derived tripeptide KPV.
Each component is studied for a distinct but complementary pathway — extracellular-matrix remodelling, angiogenesis, actin-driven cell migration and anti-inflammatory signalling — which is why the four are combined for research into overlapping tissue-repair and recovery models.
| Area | Reported research focus |
|---|---|
| Tissue repair | Combined angiogenic and matrix-remodelling pathways. |
| Inflammation | KPV-linked anti-inflammatory signalling. |
| Cell migration | Actin-driven repair-cell movement. |
| Specification | Detail |
|---|---|
| Product | KLOW Blend |
| Format | Lyophilised vial |
| Fill | 80 mg per vial |
| Purity | Specified to a 99%+ purity target — per-batch documentation will be published once independent lab testing completes |
| Price | €159.00 |
| Availability | Currently sold out — restock in progress. Join the Insiders list for the restock notice. |
| Supplied for | Laboratory research use only — not for human consumption, diagnostic or therapeutic use |
Every production batch is sent for independent, third-party analysis at Janoshik Analytical. When results return, the full Certificate of Analysis for the exact batch you receive is published here and in our COA library, carrying its SHA-256 checksum and the lot number printed on your vial, so you can confirm the document is genuine and untampered. We publish every certificate, including any that fail.
Occasional, useful email: new-batch and restock notices, the free reconstitution calculator and guides, plus FIRST10 for 10% off your first order. No daily blasts.